{
    "paper_id": "0a1d7e4f128ee76e19a5e5d2b5925791ab03b68d",
    "metadata": {
        "title": "Journal Pre-proof Smoker, Former Smoker and COVID-19: Nicotine Does Not Protect Against SARS-CoV-2",
        "authors": [
            {
                "first": "Carlos",
                "middle": [],
                "last": "Andr\u00e9s Jim\u00e9nez-Ruiz",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Daniel",
                "middle": [],
                "last": "L\u00f3pez-Padilla",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Adolfo",
                "middle": [],
                "last": "Alonso-Arroyo",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Rafael",
                "middle": [],
                "last": "Aleixandre-Benavent",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Segismundo",
                "middle": [],
                "last": "Solano-Reina",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Ignacio",
                "middle": [],
                "last": "De Granda-Orive",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "We would like to thank Moril et al. 1 for their interest in our paper and for prompting us to explore the topic further. The spike protein is responsible for facilitating the entry of SARS-CoV-2 into human cells and requires priming by protease TMPRSS2 to allow fusion of the viral and cellular membranes 2 . The receptor used by the spike protein is the angiotensin-J o u r n a l P r e -p r o o f converting enzyme 2 (ACE2) 2 , which is expressed in different cell strains, as well as in the lung, where there is a gradient of ACE2 expression (higher expression in the upper respiratory tract [nasal epithelium] and lower in the alveolar pneumocytes) 2 . It has been suggested that a higher expression of ACE2 could contribute to increased SARS-CoV-2 viral infectivity 2 . As Moril et al. mention 1 , active smokers with chronic obstructive pulmonary disease have a higher level of expression of ACE2 than former smokers and former smokers have a higher level than never smokers 1,2 , while a decrease in ACE2 expression has been observed in the bronchial epithelial cells of former smokers compared with active smokers 1,2 . Not all authors have obtained the same results. Lee et al. 3 did not identify any differences in ACE2 expression based on age, sex, or smoking status, and suggest that smoking is not a protective factor, but rather a risk factor for Covid-19 disease progression. Voinsky et al. 4 did not find higher ACE2 and TMPRSS2 expression in smokers or never smokers, but they did observe higher expression of TMPRSS4 (that encodes a protease for cell entry similar to TMPRSS2) in smokers compared to never smokers, suggesting that they may be at increased risk for Covid-19",
            "cite_spans": [
                {
                    "start": 36,
                    "end": 37,
                    "text": "1",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 652,
                    "end": 653,
                    "text": "2",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 1186,
                    "end": 1187,
                    "text": "3",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 1405,
                    "end": 1406,
                    "text": "4",
                    "ref_id": "BIBREF3"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "infection. Regarding the comment of Moril et al. 1 on the possibility of a better prognosis in smokers, Takagi, in Japan 5 , carried out a meta-regression that showed a positive association between the prevalence of smoking and Covid-19 infection independent of other covariables, so the hypothesis that smokers have a better disease prognosis is not supported.",
            "cite_spans": [
                {
                    "start": 49,
                    "end": 50,
                    "text": "1",
                    "ref_id": "BIBREF0"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "In a new meta-analysis of our data 6 , we classified patients as smokers or former smokers (only 5 articles differentiated former smokers) (Fig. 1) . Former smokers clearly showed similarly poor progression, while current smokers showed a clear tendency to worse progression but without statistical significance. The same results were obtained in the meta-analysis of Patanavanich et al. 7 (only 8 articles divided smokers into categories). Most of the studies included in the meta-analysis have significant limitations: they are mostly retrospective and have significant selection and data biases and lack a comparative group, making it difficult to establish causality. We reaffirm that smokers and former smokers have a worse Covid-19 progression, including higher mortality, and that nicotine cannot be considered a protective factor in any way.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 139,
                    "end": 147,
                    "text": "(Fig. 1)",
                    "ref_id": null
                }
            ],
            "section": ""
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "exfumador y Covid-19",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Moril",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Pe\u00f1a",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Fumador",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "Arch Bronconeumol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1016/j.arbres.2020.12.027"
                ]
            }
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Effects of cigarettes smoking on SARS-CoV-2 receptor ACE2 expression in the respiratory epithelium",
            "authors": [
                {
                    "first": "I",
                    "middle": [
                        "H"
                    ],
                    "last": "Heijink",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "L"
                    ],
                    "last": "Hackett",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "D"
                    ],
                    "last": "Pouwels",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Pathol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1002/path.5607"
                ]
            }
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs",
            "authors": [
                {
                    "first": "I",
                    "middle": [
                        "T"
                    ],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Nakayama",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "T"
                    ],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Goltsev",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "A"
                    ],
                    "last": "Gall",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Nat Commun",
            "volume": "11",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1038/s41467-020-19145-6"
                ]
            }
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Smoking and COVID-19: Similar bronchial ACE2 and TMPRSS2 expression and higher TMPRSS4 expression in current versus never smokers",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Voinsky",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Gurwitz",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Drug Dev Res",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1002/ddr.21729"
                ]
            }
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Takagi",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Intern Emerg Med",
            "volume": "15",
            "issn": "",
            "pages": "1601--1604",
            "other_ids": {
                "DOI": [
                    "10.1007/s11739-020-02473-2"
                ]
            }
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "COVID-19 and Smoking: A Systematic Review and Meta-Analysis of the Evidence",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "A"
                    ],
                    "last": "Jim\u00e9nez-Ruiz",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "L\u00f3pez-Padilla",
                    "suffix": ""
                },
                {
                    "first": "Alonso-Arroyo",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "Aleixandre-Benavent",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Solano-Reina",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "De Granda-Orive",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "I"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Arch Bronconeumol",
            "volume": "2020",
            "issn": "20",
            "pages": "30236--30238",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "EXFUMADOR Y COVID-19: LA NICOTINA NO PROTEGE CONTRA EL SARS-CoV-2SMOKER, FORMER SMOKER AND COVID-19: NICOTINE DOES NOT PROTECT AGAINST SARS-",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "Instituciones-1 Unidad Especializada de Tabaquismo de la Comunidad de Madrid. Hospital Cl\u00ednico San Carlos. Madrid. Espa\u00f1a. -2 Servicio de Neumolog\u00eda. Hospital General Universitario Gregorio Mara\u00f1\u00f3n. Madrid. Espa\u00f1a. -3 Departamento de Historia de la Ciencia y Documentaci\u00f3n, Universidad de Valencia, Valencia, Espa\u00f1a. -4 Senior Scientist & Accredited Professor. Ingenio (CSIC-UPV). UISYS, Joint Research Unit, Universitat de Valencia. Valencia, Espa\u00f1a. -5 Servicio de Neumolog\u00eda. Hospital Universitario 12 de Octubre. Universidad Complutense de Madrid. Madrid. Espa\u00f1a Autor de Correspondencia: Dr. Jos\u00e9 Ignacio de Granda-Orive. C/Cavanilles 43, 7\u00baE. 28007 Madrid. Correo electr\u00f3nico: igo01m@gmail.com To the Editor:",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": "The authors state that they have no conflict of interests. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Conflict of interests"
        }
    ]
}